GlassScriptPhysician profile
Marisa Beals
NPI 1356905319
$381.27
in general payments reported to CMS, 2019-2025
10 companies · $89.10 in 2025
The $89.10 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $92.00 · 2024: $200 · 2025: $89.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $381.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $102.16 | 2023-2025 | |
| Abbvie INC. | $59.87 | 2023-2024 | Lo Loestrin Fe |
| Coopersurgical, INC. | $40.78 | 2025 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $33.99 | 2023-2024 | Myfembree |
| Hologic Sales and Service, LLC | $31.47 | 2023-2024 | Aptima |
| Exeltis, USA INC. | $30.92 | 2024 | Slynd |
| Astellas Pharma US INC | $26.76 | 2023-2024 | Veozah |
| Pfizer INC. | $20.16 | 2024 | |
| Merck Sharp & Dohme LLC | $19.25 | 2024 | Gardasil 9, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $15.91 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marisa Beals listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.